- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/26 - Klebsiella (G)
Détention brevets de la classe C07K 14/26
Brevets de cette classe: 93
Historique des publications depuis 10 ans
|
3
|
5
|
2
|
5
|
11
|
8
|
5
|
10
|
10
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| University of Maryland, Baltimore | 1046 |
7 |
| The Regents of the University of California | 20506 |
6 |
| Pivot bio, Inc. | 149 |
6 |
| Bactoclear Holdings Pte. Ltd. | 19 |
6 |
| Pfizer Inc. | 3362 |
5 |
| Commonwealth Scientific and Industrial Research Organisation | 1659 |
4 |
| Affinivax, Inc. | 28 |
3 |
| Cornell University | 3381 |
3 |
| Oxford University Innovation Limited | 1622 |
3 |
| Vaxnewmo LLC | 22 |
3 |
| SNIPR Biome ApS | 57 |
3 |
| Evaxion Biotech A/S | 53 |
3 |
| Vaxxinova US, Inc. | 38 |
3 |
| Glaxosmithkline Biologicals S.A. | 1597 |
2 |
| Massachusetts Institute of Technology | 10196 |
2 |
| The Chancellor, Masters and Scholars of The University of Oxford | 162 |
2 |
| Evaxion Biotech ApS | 21 |
2 |
| Nomad Bioscience GmbH | 45 |
2 |
| The University Court of the University of Glasgow | 268 |
2 |
| Centre National de La Recherche Scientifique | 10870 |
1 |
| Autres propriétaires | 25 |